Press Contact
Ellen Mullally
Phone: 410-992-3124
Email: emullally@paltmed.org
Spotlight
May 25, 2023
Showing 1931 - 1940 of 8078 results
JAMDA
May 25, 2023
Trends in COVID-19–Related Medication Use in US Nursing Homes, 2018-2022
Little is known about how COVID-19 treatment patterns have evolved over time in nursing homes (NHs) despite the devastating effects of COVID-19 in this setting. The aim was to describe changes in COVID-19–related medication use over time among NH residents in the United States.
JAMDA
May 24, 2023
Long-Term Survival After Aspiration Pneumonia in Older Inpatients: A Comparative Study
Aspiration pneumonia (AsP), a leading cause of death in older people, remains poorly studied. We aimed to evaluate short- and long-term prognosis after AsP in older inpatients.
JAMDA
May 23, 2023
Prediction of Incident Depression in Middle-Aged and Older Adults using Digital Gait Biomarkers Extracted from Large-Scale Wrist Sensor Data
To determine if digital gait biomarkers captured by a wrist-worn device can predict the incidence of depressive episodes in middle-age and older people.
Podcast
May 23, 2023
JAMDA On-The-Go | May 2023 | Exploring Innovations in Fracture Care, Physician-NP Collaboration, and Exercise Guidelines
JAMDA
May 23, 2023
Social Networks Effects on Spouse and Adult-Child Dementia Caregivers’ Experiences: A Cross-Sectional Study
A large body of literature addresses experiences of spouse and adult-children caregiver of individuals with dementia (IWDs) but has not examined the role and strength of social networks in associations between spouses and adult-children caregivers’ experience. Based on the stress process model, we aimed to...
JAMDA
May 22, 2023
Factors Associated With Benzodiazepine and Antipsychotic Prescribing in Hospice: A Qualitative Study of Hospice Prescribers
Benzodiazepine and antipsychotic medications are common components of the hospice toolkit and are routinely prescribed for behavioral symptom management at end of life. These medications have significant associated risks but, despite their frequent use, little is known about how clinicians weigh prescribin...
JAMDA
May 20, 2023
Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease
The use of antipsychotics in persons with Parkinson's disease (PD) is common, although their use may aggravate the symptoms of PD. Clozapine and quetiapine are the only antipsychotics recommended in PD treatment guidelines. Information on factors associated with initiation of antipsychotics is needed....
Podcast
May 19, 2023
AMDA On-The-Hill | May 2023
JAMDA
May 18, 2023